Hoʻololi Peptide
ʻO Chelating Peptides
He aha ka Chelating Peptides?
Hoʻopili i nā peptides i nā chelator metala (e.g. DOTA, HOʻohana, etc.) hāʻawi i kahi ala maikaʻi no ke kiʻi ʻana i ka ʻiʻo maʻi maʻi a i ʻole nā lāʻau lapaʻau e lawe ai i nā oncotoxins i nā maʻi kanesa. ʻO ka interleukin 13 hōʻailona mole alpha 2 (IL13RA2) he molekele hōʻailona i hōʻike nui ʻia i ka nui o nā gliomas malignant (Nā GBM) akā, ʻaʻole i loaʻa i nā cell maʻamau. Hiki ke hāʻawi i kahi ala hou no ka mālama ʻana i nā glioma maʻi ʻo ka hoʻopaʻa ʻana i nā ligand e hoʻopaʻa ana i kēlā molekele hōʻailona. (Nā GBM). No ka mea, ua hoʻopaʻa ʻia ʻo IL13RA2 i ka IL13, ʻO kēia molekele hōʻailona he pahuhopu maikaʻi i nā lāʻau lapaʻau e unuhi i nā molekole cytotoxic maʻi kanesa i ka glioma malignant (Nā GBM) pūnaewele.Peptide-1 laina (Pep-1L) ua loiloi ʻia no kona hiki ke hoʻopaʻa i ka IL13RA2 ma ke ʻano i manaʻo ʻia, a ma o nā hoʻololi chelating, ka Linear Peptide-1 (Pep-1L) hiki ke lawe i ka cytotoxin Actinium-225, Ac-225, i ka glioma maligna (Nā GBM) pūnaewele.
ʻO ka lawelawe ʻo Chelating Peptides
Papa inoa maʻamau
ʻO ka ʻōlelo a i ʻole ka overexpression o nā molekele hōʻailona kikoʻī e nā maʻi kanesa ua alakaʻi i ka hoʻomohala ʻana o ka peptide synthesis e hiki ke kuhikuhi i kēia mau molekele hōʻailona., a me MOL Hoʻololi e hāʻawi i ka laulā o ka peptide chelator hoʻololi, me DOTA a me DTPA.
|
pōkole
|
Inoa piha
|
|---|---|
|
DOTA |
1,4,7,10-tetraazacyclododecane-N,N,N,N-tetraacetic acid |
|
HOʻohana |
1,4,7-triazacyclononane-N,N,N-triacetic acid |
|
ʻAnakē |
1,4,8,11-tetraazacyclotetradecane-1,4,8,11-tetraacetic acid |
|
DTPA |
ʻakika diethylenetriaminepentaacetic |
|
IDA |
ʻakika ʻiminodiacetic |
|
CB-TE2A |
4,11-bis(carboxymethyl)-1,4,8,11-tetraazabicyclo[6.6.2]hexadecane |
|
DiAmSar |
1,8-Diamino-3,6,10,13,16,19-hexaazabicyclo[6,6,6]-eicosane |
Kuhikuhi Manawa
New Insights in the Design of Bioactive Peptides and Chelating Agents for Imaging and Therapy in Oncology
Many synthetic peptides have been developed for diagnosis and therapy of human cancers based on their ability to target specific receptors on cancer cell surface or to penetrate the cell membrane. Chemical modifications of amino acid chains have significantly improved the biological activity, the stability and efficacy of peptide analogues currently employed as anticancer drugs or as molecular imaging tracers. The stability of somatostatin, integrins and bombesin analogues in the human body have been significantly increased by cyclization and/or insertion of non-natural amino acids in the peptide sequences. Eia kekahi, the overall pharmacokinetic properties of such analogues and others (including cholecystokinin, ʻO ka peptide intestinal vasoactive a me nā analogues neurotensin) ua hoʻomaikaʻi ʻia e PEGylation a me glycosylation. Eia kekahi, ka hui ʻana o kēlā mau peptide analogues i nā loulou hou a me nā chelators bifunctional (e like me AAZTA, ʻAnakē, HEWA, NUMBER etc.), ua hoʻopuka i nā moieties radiolabeled me ka hoʻonui ʻana i ka hapalua o ke ola a me ka pilina paʻa kiʻekiʻe i nā mea loaʻa cognate. Hōʻike kēia loiloi i nā hoʻololi kemika koʻikoʻi a hou i hoʻokomo ʻia i nā kaʻina amino acid a me nā loulou a me nā chelators bifunctional hou i hoʻomaikaʻi nui i ka kikoʻī a me ka naʻau o nā peptides i hoʻohana ʻia i ka maʻi oncologic a me ka therapy..
Nā lawelawe hoʻololi peptide pili
peptide glycosylation
peptide glycosylation
ʻO ka peptide glycosylation kahi hoʻololi covalent i hiki ke hoʻomaikaʻi i nā waiwai physicochemical o nā peptides.
Heluhelu hou akupeptide Phosphorylation
peptide Phosphorylation
Hiki mai paha ka Phosphoralation ma Serine (S, E lilo), Threonine (Ua ʻōlelo ʻo T, ʻO Thr) a me Tyrosine (Y, ʻO Tyr) nā kaulahao ʻaoʻao e ka hoʻokumu ʻana i ka paʻa phosphoester
Heluhelu hou akuNā Peptides Stapled
Nā Peptides Stapled
ʻO ka hoʻolauna ʻana i ʻelua mau waikawa amino kūlohelohe i loaʻa ka α-methyl, Nā pūʻulu α-alkenyl i ka wā paʻa-phase synthesis o nā kaulahao peptide.
Heluhelu hou akuCyclic Peptide
Cyclic Peptide
Hoʻonui ka cyclization i ka conformational stability o nā peptides (pili i kā lākou mau analogues linear) a he hoʻolālā maʻamau i ka hoʻomohala ʻana i ka peptide.
Heluhelu hou akuhoʻololi peptide
ʻIke nui i ka hoʻololi peptide, hāʻawi i nā ala kūpono he nui no ka noiʻi peptide.